Eprosartan
Back to searchMolecule Structure
Scientific Name
Eprosartan
Description of the Drug
Eprosartan is an ARB used to treat hypertension, diabetic nephropathy, and congestive heart failure.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00876
http://www.drugbank.ca/drugs/DB00876
Brand Name(s)
Teveten
Company Owner(s)
Abbvie Inc, Mylan Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Type-1 angiotensin II receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL227 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4025 | ||
| Human Metabolome Database | HMDB0015014 | ||
| DrugBank | DB00876 | ||
| PubChem: Thomson Pharma | 14929623 | ||
| PubChem | 5281037 | ||
| Mcule | MCULE-1909746156 | ||
| LINCS | LSM-43101 | ||
| Nikkaji | J553.931E | J380.264G | |
| BindingDB | 50011977 | ||
| EPA CompTox Dashboard | DTXSID0022989 | ||
| DrugCentral | 1037 | ||
| Brenda | 255908 | 27440 | |
| ChemicalBook | CB0135346 | ||
| Guide to Pharmacology | 3940 | 588 | |
| rxnorm | TEVETEN | EPROSARTAN MESYLATE | EPROSARTAN |
| ChEBI | 4814 | ||
| ZINC | ZINC000029319828 |
